Skip to primary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Post navigation

← Previous Next →

FDA Expands Use of Cystic Fibrosis Medication

Posted on October 5, 2016 by gutsandgrowth

FDA Expands Use of Orkambi ( lumacaftor/ivacaftor)

screen-shot-2016-09-30-at-7-44-33-am

Related blog post:

  • Lumacaftor-Ivacaftor for Cystic Fibrosis | gutsandgrowth

 

Share this:

  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
Like Loading...

Related

This entry was posted in Pediatrics and tagged cystic fibrosis, Ivacaftor, lumacaftor, Orkambi by gutsandgrowth. Bookmark the permalink.
Blog at WordPress.com.
  • Reblog
  • Subscribe Subscribed
    • gutsandgrowth
    • Join 932 other subscribers
    • Already have a WordPress.com account? Log in now.
    • gutsandgrowth
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d